Blinding assessment in clinical trials: A review of statistical methods and a proposal of blinding assessment protocol

Heejung Bang, Stephen P. Flaherty, Jafar Kolahi, Jongbae Park

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

There is strong consensus in the clinical trial community that blinding is an important issue in randomized controlled trials. At present grossly incomplete reporting of procedures and the use of any assessment for blinding still prevails. The term 'double-blind' has almost become a convention without any checks or balances. Also there is a lack of consensus on quantitative procedures for evaluating the success of blinding in the literature. This article reviews statistical methods of blinding assessment along with software options, and discusses some of the most pressing issues surrounding the acquisition, interpretation, and reporting of blinding data. Finally, it proposes a sample blinding assessment protocol to address some of these issues.

Original languageEnglish (US)
Pages (from-to)42-51
Number of pages10
JournalClinical Research and Regulatory Affairs
Volume27
Issue number2
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Clinical Trials
Research Design
Software
Randomized Controlled Trials

Keywords

  • Blinding assessment
  • Blinding index
  • Blinding protocol
  • Blinding questionnaire
  • Masking

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology
  • Pharmacology (medical)

Cite this

Blinding assessment in clinical trials : A review of statistical methods and a proposal of blinding assessment protocol. / Bang, Heejung; Flaherty, Stephen P.; Kolahi, Jafar; Park, Jongbae.

In: Clinical Research and Regulatory Affairs, Vol. 27, No. 2, 06.2010, p. 42-51.

Research output: Contribution to journalArticle

@article{8e955f5ec9e947469b52adb353c553ca,
title = "Blinding assessment in clinical trials: A review of statistical methods and a proposal of blinding assessment protocol",
abstract = "There is strong consensus in the clinical trial community that blinding is an important issue in randomized controlled trials. At present grossly incomplete reporting of procedures and the use of any assessment for blinding still prevails. The term 'double-blind' has almost become a convention without any checks or balances. Also there is a lack of consensus on quantitative procedures for evaluating the success of blinding in the literature. This article reviews statistical methods of blinding assessment along with software options, and discusses some of the most pressing issues surrounding the acquisition, interpretation, and reporting of blinding data. Finally, it proposes a sample blinding assessment protocol to address some of these issues.",
keywords = "Blinding assessment, Blinding index, Blinding protocol, Blinding questionnaire, Masking",
author = "Heejung Bang and Flaherty, {Stephen P.} and Jafar Kolahi and Jongbae Park",
year = "2010",
month = "6",
doi = "10.3109/10601331003777444",
language = "English (US)",
volume = "27",
pages = "42--51",
journal = "Clinical Research Practices and Drug Regulatory Affairs",
issn = "1060-1333",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Blinding assessment in clinical trials

T2 - A review of statistical methods and a proposal of blinding assessment protocol

AU - Bang, Heejung

AU - Flaherty, Stephen P.

AU - Kolahi, Jafar

AU - Park, Jongbae

PY - 2010/6

Y1 - 2010/6

N2 - There is strong consensus in the clinical trial community that blinding is an important issue in randomized controlled trials. At present grossly incomplete reporting of procedures and the use of any assessment for blinding still prevails. The term 'double-blind' has almost become a convention without any checks or balances. Also there is a lack of consensus on quantitative procedures for evaluating the success of blinding in the literature. This article reviews statistical methods of blinding assessment along with software options, and discusses some of the most pressing issues surrounding the acquisition, interpretation, and reporting of blinding data. Finally, it proposes a sample blinding assessment protocol to address some of these issues.

AB - There is strong consensus in the clinical trial community that blinding is an important issue in randomized controlled trials. At present grossly incomplete reporting of procedures and the use of any assessment for blinding still prevails. The term 'double-blind' has almost become a convention without any checks or balances. Also there is a lack of consensus on quantitative procedures for evaluating the success of blinding in the literature. This article reviews statistical methods of blinding assessment along with software options, and discusses some of the most pressing issues surrounding the acquisition, interpretation, and reporting of blinding data. Finally, it proposes a sample blinding assessment protocol to address some of these issues.

KW - Blinding assessment

KW - Blinding index

KW - Blinding protocol

KW - Blinding questionnaire

KW - Masking

UR - http://www.scopus.com/inward/record.url?scp=77952569050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952569050&partnerID=8YFLogxK

U2 - 10.3109/10601331003777444

DO - 10.3109/10601331003777444

M3 - Article

AN - SCOPUS:77952569050

VL - 27

SP - 42

EP - 51

JO - Clinical Research Practices and Drug Regulatory Affairs

JF - Clinical Research Practices and Drug Regulatory Affairs

SN - 1060-1333

IS - 2

ER -